Search results
Author(s):
Tian-le Li
,
Mao-long Fu
,
Li-hong Wang
,
et al
Added:
8 months ago
Author(s):
Tian-le Li
,
Mao-long Fu
,
Li-hong Wang
,
et al
Added:
6 months ago
Author(s):
Wei Gao
,
Hui Wang
,
Jian-long Wang
,
et al
Added:
4 weeks ago
Author(s):
Amish Raval
Added:
8 months ago
ACC 2025 - Principal results from autologous cell therapy in patients with heart failure with reduced ejection fraction (HFrEF) show favourable safety outcomes, however, the study did not meet its primary efficacy outcome using 6 minute walking rests as 3rd F-S tier.Dr Amish Raval (UW Health University Hospital Interventional Cardiology Clinic, WI, US) joins us onsite at ACC to discuss the…
View more
Author(s):
Fatin Fazrina Roslan
,
Yuexin Yu
,
Nurul Ain Nasim Mohd Yusof
,
et al
Added:
1 year ago
Author(s):
Camilla Olianti
,
Mauro Giacca
Added:
2 months ago
Author(s):
Massimiliano Camilli
,
Luca Maggio
,
Lorenzo Tinti
,
et al
Added:
8 months ago
Hui Wang
Research Area(s) / Expertise:
Author
Expertise
Wei Gao
Research Area(s) / Expertise:
Author
Expertise
Author(s):
Subodh Verma
Added:
3 months ago
ESC Congress 2025 - The SEMA-VR CardioLink-15 trial revealed that semaglutide may enhance endogenous progenitor cell-mediated vasculogenic repair processes.Dr Subodh Verma (University of Toronto, Toronto, CA) joins us to discuss the findings from the SEMA-VR CardioLink-15 trial. The study compared usual care with semaglutide, GLP-1RA for six months in 46 patients with either type 2 diabetes…
View more